[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CA1171413A - Synthetic method and intermediate for piroxicam - Google Patents

Synthetic method and intermediate for piroxicam

Info

Publication number
CA1171413A
CA1171413A CA000386690A CA386690A CA1171413A CA 1171413 A CA1171413 A CA 1171413A CA 000386690 A CA000386690 A CA 000386690A CA 386690 A CA386690 A CA 386690A CA 1171413 A CA1171413 A CA 1171413A
Authority
CA
Canada
Prior art keywords
piroxicam
ester
hydroxy
methyl
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000386690A
Other languages
French (fr)
Inventor
Joseph G. Lombardino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Priority to CA000445578A priority Critical patent/CA1181749A/en
Application granted granted Critical
Publication of CA1171413A publication Critical patent/CA1171413A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

P,C, (Ph) 6341 SYNTHETIC METHOD AND
INTERMEDIATE FOR PIROXICAM
Abstract 2-Methoxyethyl 4-hydroxy-2-methyl-2H-1,2-benzothia-zine-3-carboxylate 1,1-dioxide is an advantageous ester precursor fpr piroxicam (4-hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxidel, an antiinflammatory agent established in medical practice.

Description

~. a~

~1.~

Sy~THETIC ~ETEI(3P AND
~ENTER~EPIATE ~OR PI~ROXI:C:A~

T~,s ~n~enti~on. i,s concerned wi~t~.'2~m~th~xy~thyl 4-hydroxy~2~me.t~yl~2H~1,2~enzoth~azi,ne..~3-car~oxylat~ .
l,l-dioxlde.,', 0~ 0 ~C~C}I3 CI
~NCEI`3 O

an ester ha~ing spec~.al value. ~n t~ synthesis of pirox;,cam C4-hydroxy-2-methyl-N~2~pyr~dyl~2H~1~2-benzo~
thiaz~ne-3-car~oxamide 1,l-d~ox~de~

~f \ I OEI2 _. S~Nc~3 H
O O
an antiinflammatory agent of estabIished value in the medicinal art. It ~ill be noted that in past practice, the acyl rad;cal of compounds of this type has been sometimes written as O O

~'~
Q

and s~ch.compoun,d~s. ~lte~na,t~ e.ly na,m,e~ ~ 3,4~d~d~o-
2~et~ 4-oxo~2x-l~2~enzot~azl~ne ~ di~oxi~de~deri~
: tives~ Those's~i~lled ~n th.e.'art w~ll understand tha,t ~,, ~2~

the~e. ar~ e.qui~ya,len,t taj~tome~ c ~ o~ the ~a~e.
compo~nd. The'present i~nYenti~on ls. ~,ntended tq e~co~p~ss both.tautomer,ic $orms w~ ,i,ti~n~ only one of the~
as a matter o~ conVen.i,ence~
~i~oxica~ was ori:gInally dtsclo~ed by ~om~ardino CU~S~ Patent 3,'5~1,584~t One o~ t~e processes ~or the synthesis~ o~ pirox~cam d~sclosed th.erein is to react a 3-carboxyl.c ac,~,d este~ ~t~ 2-am~nopyr~d~,ne, ~ore spec~ficall~, th.e ester ~s d~sclosed as a CCl-C121alkyl, ester or phenyl.CCl~c3~al~yl ester~ The specif~,c ester - described is t~e met~l,ester, yi,z~
OH O
I ll CH
O ~ 3. ~II

0~
~See also Lombardino e~ al., J. ~ed. Chem. 14, pp, 1171-1175 ~1971)]. A d;sad~antage in this ot~erwise useful process for piroxicam lies ln the varia~le formation of quantities of ~ highly colored byproduct. This highly colored byproduct, whic~ is removed only by multiple recrystallizations with major product loss, lends an unaccepta~le, strong yello~ color to the piroxicam bulk product, even when present at ~ery.low levels (e.g., 0.5-1%). This byproduct has been isolated and determined to have the following structure:

~NH~

O O
It ha's~ ~een $hown tha't ~ s ~ctually formed ~s ~
~yproduct in the re~ction, rather than being de~ved from . ~3~
a contaminant in t~e. pre.cursor. How this compound is actually formed in. the reaction mi~xture is not ~ully understood, although ~ethod$ wh;~.c~.are. directed to rap~d remoyal. o~ t~.e.me.thanol ~yproduct as ~it is for~ed in. t~e react~on appea~ tQ reduce the incidence o~
piroxicam ~atches ha:ving unaccepta~le. color, ~o~e.yer !
these methods are o~ uncertai~n dependaB~l~t~ and a goal has been to ~ind an ester ~h~ch Xs readily aya~
able by synt~esIs and w~:c~.does not gi:ye rise to an ether such as ~IVl as ~ troubleso~e.Byproduct durin.g conversion to p~ro~icam.
Alternative syntheses o~ piroxicam which have been disclosed in the literature. ~nclude reaction of 3,4-dihydro-2-methyl~4-oxo-2H-1,2-ben~.othtazine 1,1~
dioxide w;th 2-pyridyl isocyanate ~ombardino~ U,S.
Patent 3,5~1,5841 ! transam;dation of 4~hydroxy-2-methyl~
2H-1,2-benzothiazine-3-carboxanilides ~ith 2-aminopyridine (Lom~ardino, ~.S Patent 3,8~1,637~, cyclization of -~ CO ~ -C ~ lk 1 W 5O2NC ~CON~

20 (lombardino, U.S. Patent 3,853,B6~, coupling of a ~
4-(Cl-C3)alkoxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid l,l-dioxide with 2-aminopyridine followed by hydrolysis of the enol;c ether linkage (Lombardino U.S~
Patent 3,892,740)r couplin~ of 4~hydroxy~2-~ethyl~2H~
1,2-benzothiazine~3-carboxylic ac7 d, yia the. aCIa c~lQride, wit~.2~aminPpyr;di~ne~ enl ~S~ ~a~çnt 4~0Q~347~_ an.d methylati~.on.~ 4=hydr.ox~-N~2-.px~ dyl~2H~1,2~.BenzQtA~i~az~l~n~
3-car~oxa~i~e. (~anad~ ~atent 1,~g,8g:.4~ t Anot~er e~ter.xelated to t~e me.thoxyethyl ester o~ the present invention w~i~c~ Ra`s been speci~ically described ~n .~'7.
~4 the lIterature. i:s ethyl 4~h~droxy~2~methyl.~2H-1,2~benzo~
t.h~az~ne-3-carhoxy~late~ l,.l-d~oxIde. CRa,s~u~en,. .U.S.
Patent 3750.1,466i s~e. ~l~o Z~nnes et ~ls! U~t P~tent 3~816~8~s , .

, - .

~5~

The 2~met~oxyet~1 estex ~,I, ~as ~een synthe~ized.
In the.known proces,s o~ con~ertl`ng a corresponding 3n car~oxyli~c aci,d este~ to pirox~,cam, t~s ester has been su~sti,tuted ~or t~e.'pr,~or axt ~e~yl este~ , Use o~ t~e noveI este~ C~ ~as tfi~ surpr~sI,n~ advanta,ge that the p-'rox~,cam so produced conta;'ns no detecta~le le~el of the. expected,.~;ghly~colored eth.e~ ~yproduct I4~ ~
methoxyethoxyL~2-~ethyl~N-2~p~ridyl-2H~1,2 ~enzothiazine-3-cax~oxamide~, of t~e ~ormula CH2C~20CH3 ~

~ N -~ ~NCH~ H ' ~Y

O Oanalogous to the ether ~IV~', ~6.~

Deta~;led Desc~ t~on o~ the InYention T~e. ~qu;~red 2~met~sx~ethyl estex QIL is xea,dily prepaxed fro~ sacch~n-2~a,cetate ester I2_~eth~x~ethyl~
3~oxo-2H;~l~2-~enz~,sot~'azol~n2-2~aceta,te l,l~d~oxide, formula C~ y~ th.e.'$ollo~,i,ng sequenc~ o~ re~ct~o~s ~NC~I2COOCX~CH20CH3 ~b-3~ EYIl C}~30C~2C}~2o 1 ~e~rraDgement OH
~COOcH2cH20cH3 L~JII 1 ~NE
O O, methylation , ~ r ~COOCH2CH20CH3 O O
The rearrange~ent ~,~ ca~r~ed out by t~e~t~ng t~e intermediate saccha,~ n,-2~a~ceti~,c ac,~d e~tex ~t~
alkoxide, p~e~e~a,~ly a~ 2~-~thoxy~thox~de s~ch. ~s sod~um 2-methsx~e.thQx,i~d~ ~n orde., to .a,Vo~ e compli~cat,~,on o~ trans~es~tex~ cat,i.on.~ in a polar organic solyent such'as d,i~et~l sulfox~de or dl~et~
formamide., ~eth~lat~,on ~s accompl ,s~èd By a met~.~lat~n~
agent, suc~ as dimet~yl sulfate or a methyl halide, ,,t7~ 3,,3 ~7~

conyen~entl~ ~ethyl ,i~od,i~da~ ~n a react~on~i~e~t s~lyent such.'as a lower ke.ton,e.,,a lowex alkanolr fo~a~ide,~
d.imethyl~o~m~,id~ o~ m,~t~yl~ul~Qxi~de~
The~'sacc~ar,i,n,-2~acet',ic ac~d ester re.s~Ixed a~
sta~t~ng ma,te~i~al in th.e~ ab~ye'~se~uence~ is prepared ~ro~
saccha~in and 2~me.thoxye.th.yl c~Ioroacetate ~n ana,log~
to the method for preparation o~ the c~rrespond~,ng met~yl ester IChemIsc~e ~erichte.3Q, pç 1267. a8~7~, or, less~ dIrectly~ ydrolysl's o~ sa.~d me.thyl ester to the corresponding saccharin acetic ac~d and couplin~, such as Via the acid c~lor~de~ w.ith 2 methoxyethanol, The reaction o the methoxy ester CIl W~th 2~.amino~
pyrid;ne to produ~e piroxicam, - OH O ~ -= N~ N ~I~, .. ~ Y
- C~

15 is generally conducted by mixing the two components together in a reaction-inert solvent system at or near room temperature, and t~en heating the resultant system at 115-175 C. for a period of about one-hal to several hours. Although it is only necessary that these two reactants be present in substantially equimolar amounts in oraer to effect the reaction, a slight excess of one . or the other (,and preferably the more readily available - amine base reagentl is not harmful in this respect and may even serve to sh;ft the ammonolys.is re~cti~n to completion.. Pre~exred ~eactiQn~inert organ~,c ~olyent~
for use in the. a~m,on~lys,~s- ~eaction i~nc~de ~c~ lo~er N~N-dial~yl~lka~n.a~i,des as dime.th.~ r~amide~ di~ç.t~
aceta~,i.de and the li~ke.., a~s; ~ell ~ such.`aro~at~c ~ydro~
carbons solvents as Be`nzene~, toluene, ~ylene. and so ~orth, ~8 In any eyent,,~,t ~s ~ound ~QSt ~elp~ul ~nd usu~
~suitaBle.to d;~st~ll o~ t~e vo:L~t~le. alcohol. b~product as i~t ~ or~ed ~n the'~ea,ct~on ~nd thereB~ shi~t the ammonolysi~s equi~ r~um to comple-tion i~n th~s ~anner.
In the. pre ent instanc~, t~,e ~,st hi~hIy pre~er~ed sol~ent ~s xylene,' si~n,ce ~yproduct 2-~et~oxyet~anol ~s effici~ently remo~ed as a lower boil~ng azeotrope. The volume o~ xylene can ~e ma~nta:'~ned By the ~dd~tion of more'xylene during dist~,llattone After removal of the alcohol and complett,on o~ tfi.e. reacti.on t the resultIng piroxicam is con~eniently recovered by cooling and simple f~ltrat~on of the crystall~zed product~ If desired, the piroxicam ~s recrystalli.zed from d~met~ylacetamide~
acetone/water.
The present in~ention ~,s illustrated by the follow;ng examples., ~owever, it should be understood that -the invention i~s not lim~ted to the specific details of these. examples.

r-~

EX~qPI.
4-~2 Methoxye.thoxy~L~2~methyl-N~2-pyri~yl~2 1~2-benzc~th~azine~3~carBo~amide lrl~D~i.oxi.de ~o4-~(2-~ethoxye.th~l~piroxicama In a flame dried .~las~ ma~rlta.~.ned ~nde~ a~ dr~
nitrogen atmo~sp~ere~ p~i~rox~cam Q,814 g~ 5~47 mmolesL
was dissolved in 13~ o~ dr~ cli~m~thyl~or~ami`de~ Sod~um ~ydr~de. ~.131 g.., 5..47 mmolesl ~as added ~lo~.ly in porti.ons and th.e. result~ng mtxtu~e heated ~t 4Q~45Q C, for a~out 3 hours~ until suc~ time as t~e sodi.um h~dr;de had completely reacted. .2~ethoxyet~yl c~loride Ll ~ O ml ~, 0.94 mmolesl and sodiu~ ~od~de C~.821 g., 5~47 mmolesL
were then added and the reaction t~en heated at 8~ C.
for 51 hours. The cooled reaction mixture ~as di.luted with.a~out 5Q g. of ic~ and extracted with f~e 10 ml.
portions o~ methylene chloride~ The organic extracts were combined, ~ack-washed ~ith seven lS ml. portions of water, was~ed once with ~r;ne, dried over anhydrous magnesium sulfate, ~;:ltered and evaporated to an oil (I.44 g.~. The o~l was triturated with ether, yielding .soltds (.Q. 84 g~ 1 f which were recrystallized from acetonitrile CYielding 0.57 g.~. Recrystallized product ; (0.45 g.) was chromatographed on silica gel (13.5 g.), eluting with 2:3;6 methanol:cyclohexane;ethyl acetate and monitoring by TLC (same eluant~ with phosphomolybdic spray. Early cuts, containing clean product, were combined, evaporated in vacuo to solids. The solids were chased with. car~on tetrachloride and dried under high vacuum yielding O4~t2 methoxyethyl~piroxica~, ~0.31 g.; m.p. 155~15.7 C,; -~ Q.5 f2~3:~ methanolic~clo~
hexane;ethyl ace.tateI; R~ ~4 aQ;4;3 xylen.e;~tha.nol;

wateL~; Rn~rfCDC13~1delta 3.1~ 3El~, 3.35. (-s( 3HL~
3. 68 (~ 2H)! ~5.,23, ~ 2H.)~ 7 2 (~ lH~.r 7.~.C~, ~f 8.9: (~, 2H.)r 1~.2 (~road s, lH~ 5 ~ r~

~ 0~.

EX~MPI.E 2 2-Me ~ e._hyl 2~ChIoroacetate ~ ainta;~ni~ng a tempera~ture.o$ r~5 to 5 C-r 2~chloro-acetyl chIor~de. (11~2 g~ a,la 1~ole~. ~n 15 ml~ o~
meth~lene chlor~de was added dropw~i.se~o~çr 1 hou~ to a cold solution of p~ri.~ne C8.a.g~ Q.ll moleL and 2~methoxyethan.ol a.6 g,, Q:.lO ~oleI in 35 ~1~ o~
meth~lene chIoride. T~e Xeaction m~xture wa$ st~xred ~or a further 1 hour ~t ao C~r~ warmed to room temper~tuxe and extracted with.t~o 5~ ml~ port~ons of water~ The two asueous extracts were com~ined and ~ac~washed with. 50 ml.
of chloro~orm. The origInal organic layer and chloroform back-wash were comb~ned and was~ed w.ith 5Q ml~ o~ 5%
copper sulfate. The 5% copper sulfate wash was backwashed with 25 ml. of chloro$orm and recombined wit~ the organic phase. Finally, the organic phase was washed w~th. 50 ml.
of br~ne, treated w~t~ activated car~on and anhydrous magnesium sulate, ~iltered, concentrated to an oil and distilled to yield 2-met~oxyethyl 2-chloroacetate (14.1 g.; b.p. 80-82 C,~.
.

'71 ~
~11~

EX~LE 3 2~.Me.thoxy~th~l 3~0~o~2H~1~2~Benz~,~,othi,a,zol~ne.
2~ace.t~te, l~ D;~.oxide.
('2-Metho~y~tn~l Sa~cchari:n-2~acetateL
''''''''''~VI`~'''''' .. .. . . ... . .
Sod~,um sacchaxin a8 ~., o.a88 moleL and 2..~et~oxy~.
et~l 2-chloroacetate'Q3~'4 s.V'Q.Q88 ~ole.) were com~ined ~n 40. ml. o~ a~methyl~or~a~ide'and ~.eated at'l2Q C. Xor 4 ~ours. T~e react~on.~xture was cooled to 25q C~
lQ poured ~nto lOa ml. o~ w~ter, ~ranulated ~t 5~1Q C.
for Q.5 hour, filtered ,~t~ w~ter ~as~ and air d~ed to y~eld 2-methoxyeth~l sacc~ar;n-2~acetate I23.2 g., 90~; m.p. ~ 2 C.; mfe 2~9; irGKBrI 2~85 cm`'l~.

nl2.~

EX~$;~LE 4 2-.M~thoxyethyl 4~Hydroxy-2H~i't2~
' benzothi:azine--3icar:iox~late 1, l~di:oxide ~ , . .
Under a d~ n.~'trogen at~osphere, 2-~eth.o.x~ethanol Q2.,~. ml~ 9.24 mole~ wa~ charged to a stlrred, fla,me-dried flask... Sod,i,u~ sph.ere~, Q~.6 ~ ! .Q-4~3 ~ale.~
pentane wasA.ed and ,sl g~t'l~ 1attened wi,th'tweezex~L
were adde.d portionwise'o~er 2 ~ours, keeping the te~
perature of the react,~Qn m,~xture ~n t~.e xan~e o~
25-45 C~ ~fter an add~i~t,i,onal 1 hour o~ st~r~ngt ~
fuxther }0 ml. of 2~met~oxyethanol was added and the xeaction m~xture warmed to 57 C~ On sl;ght cooling the react~on mixture sol;d~f~ed~ The reactlon ~ixture ~as thinned wi~ 75 ml. o$ dr~ dImet~ylsul~oxide and a s~ngle remaining particle of sod;um metal removed mechanically.
The 2-methoxyethyl s~ccharin-2-acetate C50 ~., 0~.167 mole~
in 7Q ml. of warm, dry d~methylsuloxide w~s added dropwise oyer 20 minutes. The reaction m~xture was stirred..for 1 ~our at ambient temperature~ ~uenched into ~ mixture of concentrated hydrochlor~.c acid ~276 ml.~
and water ~1.84 1.~, maintaining the temperature of the quench at 20-25 C. ~y an ice-water bath and rate of addition. The slurry was granulated at 6-8 C. for 1 hour, filtered wit~ cold water wash and dried in air to yield 2-methoxyethyl 4-hydroxy-2H-1,2-benzoth~azine-3-carboxylate l,l-dioxide r32.8 g., 66~; m~p. 120-122 C.;
ir(KBr) 3448, 3226 cm 13.

~13~

EXA~L,E 5 2~ethDxyethyl 4-Hydroxy~2~met~yl~2H~ 2 ~enzoth~,azine.-3-c~rb~xylate l!l-Di~o~ide.
. ..
; 2-~et~ox~ethyl 4-hydroxy~2Hrl~2-~enzoth~a~z~ne~
3-car~oxylate. l~l~di~ox,id~. BI~I y., a~ 1~35 m,ol~ was com~ned with'23Q. ml. o~ ac~tone and cooled to lQ C~
Methyl ,~,od,~,de. ~21.9 ~ .155 mole.~ wa~ added~ followed b~ t~e drop~,se add~,tion~. ~Ver lQ ~nutes,. o~ sod,,u~
hydroxid~ Q0.3~5 ml.. o~ lM~. Th~ cooling ~a,th.~as ~emoyed and the ~eact~,on mI.xtux~ allowed to ~1Q~1Y ~r~ to room temperature Ca.~out 45 m~nutes~, then heated at 35 C, for 2 hours and f;nally at 3g-40~ C. for 16 hour~ The reaction mi.xture. was cooled to room temperature, diiuted with 20a ml. of aceto~e, treated w,it~ act~vated carbon, filtered and concentrated ;n vacuo at Q-~ C. to about 50 ml. ~he resulting slurry ~as ~lteFed~ and solids washed w;th ice-water and then dried in vacuo to yield 2-meth,oxyethyl 4~hydroxy~2~met~y1~2H-1,2 ~enzoth~azine~
3-car~oxylate l,l-d;ox~de ~2~.26 g., 9,0~; mOp. lQ6 lQ7.5 C.; mfe 313; ir(KBr~ 3345, 2941, 1684, 1351, 1053 cm l]o ;

~14~

EX~PLE 6 4~Hyd~oxy 2~ethyl-N-2-pyridyl~2~ 2-~enzoth~,azi~ne-3-carbQxamide l~l~D ,i,ox~,d~
.(P~rox~cam~
- - '''G~
2,~athoxyethyl 4~hxdxo~y~2~ 2-~enzoth ,az~ine~3 carBoxylate'l,l-dioxide L28 y~ a8~ mole~ and 2~am,~no~
p~r~d~ne C~26 g.,,O:.Og8 mole.~. ~eXe. com~ined ~th~
, 50.0 ml. of xylene'in ~ 1 liter ~lask e~uip~ed w~th.an add;tion ~unnel and a re~lux, variable take~off d~sti,l~
lation ~ead~ T~e. stirred react~on m~xture was heated to xe~lux and th.e xylene di.stilled at the rate o$
approximatel 1~0 ml~hour, while ma;~ntaining t~e pot volume almost constant by t~.e. addît~on o~ ~resh ~lene.
After 6 ho~rs, the ~ead temperature, which had been relatively constant at 134Q C~ rose to 142 C, and reflux rate slowed~ The reaction mixture was then cooled in an ice-bath.and the precipitated sol~ds ~ecovered by ~iltrat~on, w~th hexane for transfer and wash! and dried at 45 C. in vacuo to yi,eld pirox~.cam ~28.5 g., 96~;
m.p. 167-174 C.),. This product was examined by high performance liquid chromatography using 60:4Q 0.1~
Na2HPO4 adjusted to pH 7.5 wit~ citric acid;methanol ; on Micro-Bonda pak C18 Crrademark of Waters Associates 25 for a standard hplc column packing consisting of s;loxy subst~tuted silica coated on micro-glass ~eads.~ Under the conditions employed, piroxicam has a retention time of about 6 minutes,~whereas the potential contaminant, O -methoxyethylpiroxicam, has a retention time of 16.5 m;nutes. None o~ the.potential contaminant was de.tected in the. product o$ t~e p~esent Exa~pl~.
For pu,r,poses of recrysta,lli~ation~ e a~.,oye pirox~cam c25 ~..L was ~a~en u~ n lgQ ml~ o~ d~e,.t ~ l~
ace.ta,m,i~de at 70~75~ C~, treated w~i,t~.1.26. ~: o~ a~ct~yated ca,r~on at 75'-80~ C~ and fi~lte~ed throug~'di~atomaceous .

.a~
~15-.

e~xth wi~th 55 ml~ o~ war~ d~ethyl~ce.ta.~idQ ~or trans~er and wash. ~ m;xture.o$ 173 ~1. o~ a,cet~ne. a,nd 173 ml.
of ~ater was cooled to.5~ C!, THe car~on~treated ~ltrate was added slowly oyer lQ.-15 ~.nutes to t~e c~I,lled a.que.ou,s~ ace.tone.~' and tli.e ~esult~n~ crystal$
granulated at 0.-5 C~ ~or 5 m;nutes,. Rec~sta,ll;zed piroxicam was reco~ered ~ ~iltrat~on .~,it~ 154 ml~ of cold met~an~ ~for trans~er and was~. YIeld,' 18~75 g~ f 75%; ~r(:n~ l mull~ ident~cal ~r~,t~ aut~entic piroxicamt e r~,~a r ~

Claims (3)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for converting an ester of the formula to piroxicam which comprises reacting said ester with 2-aminopyridine in a reaction-inert organic solvent at 115-175°C.
until the reaction is substantially complete.
2. A process of claim 1 wherein the solvent is xylene.
3. A process of claim 1 or 2 wherein byproduct 2-methoxyethanol is removed by codistillation with solvent during the reaction.
CA000386690A 1980-09-29 1981-09-25 Synthetic method and intermediate for piroxicam Expired CA1171413A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000445578A CA1181749A (en) 1980-09-29 1984-01-18 Process for the preparation of 2-methoxyethyl 4- hydroxy-2-methyl-2h-1,2-benzothiazine-3-carboxylate 1,1-dioxide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/191,716 US4289879A (en) 1980-09-29 1980-09-29 Synthetic method and intermediate for piroxicam
US191,716 1980-09-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000445578A Division CA1181749A (en) 1980-09-29 1984-01-18 Process for the preparation of 2-methoxyethyl 4- hydroxy-2-methyl-2h-1,2-benzothiazine-3-carboxylate 1,1-dioxide

Publications (1)

Publication Number Publication Date
CA1171413A true CA1171413A (en) 1984-07-24

Family

ID=22706653

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000386690A Expired CA1171413A (en) 1980-09-29 1981-09-25 Synthetic method and intermediate for piroxicam

Country Status (30)

Country Link
US (1) US4289879A (en)
EP (1) EP0049099B1 (en)
JP (2) JPS5788172A (en)
KR (1) KR850000923B1 (en)
AR (1) AR228373A1 (en)
AU (1) AU528125B2 (en)
CA (1) CA1171413A (en)
CS (1) CS228520B2 (en)
DD (1) DD202151A5 (en)
DE (1) DE3171404D1 (en)
DK (1) DK148232C (en)
EG (1) EG16103A (en)
ES (1) ES8206518A1 (en)
FI (1) FI72719C (en)
GR (1) GR75772B (en)
GT (1) GT198171634A (en)
HK (1) HK52287A (en)
HU (1) HU186785B (en)
IE (1) IE51598B1 (en)
IL (1) IL63938A0 (en)
MY (1) MY8700511A (en)
NO (1) NO158061C (en)
NZ (1) NZ198475A (en)
PH (1) PH18475A (en)
PL (1) PL130042B1 (en)
PT (1) PT73738B (en)
SG (1) SG23187G (en)
SU (1) SU1122224A3 (en)
YU (1) YU42428B (en)
ZA (1) ZA816706B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434164A (en) 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
IN158333B (en) * 1981-08-03 1986-10-18 Pfizer
GT198276334A (en) * 1981-08-03 1984-01-10 PROCEDURE AND INTER-MEDIA FOR THE PRODUCTION OF BENZOTIAZINE CARBOXAMIDES.
US4376204A (en) * 1981-10-05 1983-03-08 Pfizer Inc. 3-Hydroxy 2-methyl benzisothiazolines as intermediates in production of piroxicam
IN159273B (en) * 1981-10-05 1987-04-25 Pfizer
CA1197244A (en) * 1982-04-16 1985-11-26 Medichem, S.A. Process for the preparation of 4-hydroxy-2-methyl-2h- 1,2-benzothiazine-3-carboxamide-1,1-dioxides
SU1306476A3 (en) * 1982-06-17 1987-04-23 Пфайзер,Инк (Фирма) Method for producing 2-methyl-3-n-(2-pyridyl)-carbamoyl-3,4-dihydro-2h-1,2-benzthiazine-1,1-dioxide
EP0098422B1 (en) * 1982-07-07 1987-12-09 Siegfried Aktiengesellschaft Process for preparing 4-hydroxy-2-methyl-n-2-pyridyl-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide
IT1153293B (en) * 1982-10-22 1987-01-14 Francia Famaceutici S R L DERIVATIVES OF 4-HYDROXY-2-METHYL-2H-1, 2-BENZOTHIAZINE-3-CARBOSSAMIDE 1, 1-DIOXIDE AND PROCEDURE FOR THEIR PREPARATION
FI72317C (en) * 1983-10-06 1987-05-11 Pfizer PROCEDURE FOR THE FRAMEWORK OF PHARMACEUTICALS 2-METHYL-4-HYDROXY-2H-1,2-BENZOTHIAZINE-1,1-DIOXIDE -3- (N-2-PYRIDYL)-CARBOXAMIDE
WO1987006933A1 (en) * 1986-05-16 1987-11-19 Pfizer Inc. Benzothiazine dioxide derivatives
ES2002646A6 (en) * 1987-03-27 1988-09-01 Induspol Sa Process for obtaining 4-hydroxy-2-methyl-N-(2-piridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide.
WO1989003682A1 (en) * 1987-10-26 1989-05-05 Pfizer Inc. Benzothiazine dioxide derivatives
FR2942797B1 (en) * 2009-03-03 2011-04-29 Pf Medicament BENZOTHIAZINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3501466A (en) * 1967-11-30 1970-03-17 Mcneilab Inc 3-carbamoyl and 3-alkoxycarbonyl benzothiazine-1,1-dioxides
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
US3853862A (en) * 1973-04-23 1974-12-10 Pfizer Production of 4-hydroxy-1,2-benzothiazine-3-carboxamides
US4074048A (en) * 1976-05-10 1978-02-14 Warner-Lambert Company Process for the preparation of 4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides

Also Published As

Publication number Publication date
YU42428B (en) 1988-08-31
FI813003L (en) 1982-03-30
IE51598B1 (en) 1987-01-21
AU7569881A (en) 1982-04-08
PT73738A (en) 1981-10-01
SG23187G (en) 1987-07-10
JPS632434B2 (en) 1988-01-19
MY8700511A (en) 1987-12-31
PL130042B1 (en) 1984-07-31
IL63938A0 (en) 1981-12-31
HK52287A (en) 1987-07-17
NO813290L (en) 1982-03-30
HU186785B (en) 1985-09-30
DE3171404D1 (en) 1985-08-22
DD202151A5 (en) 1983-08-31
PH18475A (en) 1985-07-18
GR75772B (en) 1984-08-02
NO158061B (en) 1988-03-28
KR830007604A (en) 1983-11-04
NO158061C (en) 1988-07-06
GT198171634A (en) 1983-03-19
PL233212A1 (en) 1982-08-30
AR228373A1 (en) 1983-02-28
EG16103A (en) 1987-10-30
YU230981A (en) 1983-06-30
CS228520B2 (en) 1984-05-14
NZ198475A (en) 1984-07-31
ES505851A0 (en) 1982-08-16
ES8206518A1 (en) 1982-08-16
EP0049099B1 (en) 1985-07-17
JPH0315638B2 (en) 1991-03-01
PT73738B (en) 1983-11-08
US4289879A (en) 1981-09-15
JPS5788172A (en) 1982-06-01
JPS61112064A (en) 1986-05-30
AU528125B2 (en) 1983-04-14
DK428781A (en) 1982-03-30
SU1122224A3 (en) 1984-10-30
FI72719B (en) 1987-03-31
FI72719C (en) 1987-07-10
DK148232C (en) 1985-10-21
KR850000923B1 (en) 1985-06-28
DK148232B (en) 1985-05-13
ZA816706B (en) 1982-09-29
EP0049099A3 (en) 1982-09-08
EP0049099A2 (en) 1982-04-07
IE812233L (en) 1982-03-29

Similar Documents

Publication Publication Date Title
CA1171413A (en) Synthetic method and intermediate for piroxicam
EP2855467B1 (en) Processes to produce certain 2-(pyridine-3-yl)thiazoles
CA1067079A (en) Nitrogen-containing heterobicyclic compounds
EP2855466B1 (en) Processes to produce certain 2-(pyridine-3-yl)thiazoles
KR100222309B1 (en) Substituted 2-acylamino-5-thiazole, their preparation and pharmaceutical composition containing them
CA2137976A1 (en) Thienothiazine derivatives
CZ196693A3 (en) Thiazolidinedione derivatives, and process for preparing thereof
JPH06345724A (en) Cyano compound and its production
WO1996020936A1 (en) Novel thiazolidin-4-one derivatives
FI79319C (en) Process for the preparation of novel therapeutically useful tricyclic a oxindol carboxamide derivatives
US4684658A (en) Anti-thrombotic ortho-condensed pyrrole derivatives, compositions, and method of use therefor
CA2120395A1 (en) Thiazolopyrimidine derivatives
AU2013272006A1 (en) Processes to produce certain 2-(pyridine-3-yl)thiazoles
US4090020A (en) Thienothiazine derivatives
JP3440196B2 (en) Method for producing thiobenzamide derivative
NL8300304A (en) SUBSTITUTED 1,3,4-THIADIAZOLO3,2-A PYRIMIDINES AND METHOD FOR THE PREPARATION THEREOF.
HU196215B (en) Process for producing pyrrolo-thiazoles
HU194199B (en) Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agents
KR850001223B1 (en) Process for preparing piroxicam and intermediates leading thereto
Nagarapu et al. Synthesis of phenylimidazo thiazolo benzocycloheptene derivatives as potential antiinflammatory agent-IV
US4376204A (en) 3-Hydroxy 2-methyl benzisothiazolines as intermediates in production of piroxicam
KR20020087835A (en) Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
CA1181749A (en) Process for the preparation of 2-methoxyethyl 4- hydroxy-2-methyl-2h-1,2-benzothiazine-3-carboxylate 1,1-dioxide
EP0146102A2 (en) Process for preparing benzothiazine compounds
EP0440319A1 (en) Process and intermediates for the preparation of annelated iminothiazoles

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry